Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Growth hormone and lipids].

M Maccario1, L Gianotti, S Grottoli

  • 1Università degli Studi, Torino.

Minerva Gastroenterologica E Dietologica
|February 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relacorilant or surgery improved hemostatic markers in Cushing syndrome.

Journal of endocrinological investigation·2024
Same author

Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly.

Journal of endocrinological investigation·2024
Same author

Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy.

Journal of endocrinological investigation·2024
Same author

Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis.

Journal of endocrinological investigation·2024
Same author

Once upon a time: the glucagon stimulation test in diagnosing adult GH deficiency.

Journal of endocrinological investigation·2024
Same author

A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas.

Journal of endocrinological investigation·2024
Same journal

Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration.

Minerva gastroenterologica e dietologica·2021
Same journal

Diagnostic accuracy of computerized tomography (CT) angiography in detecting non-variceal gastrointestinal bleeding (NVGIB): a sistematic review.

Minerva gastroenterologica e dietologica·2020
Same journal

Helicobacter pylori and non-alcoholic fatty liver disease.

Minerva gastroenterologica e dietologica·2020
Same journal

Hypertriglyceridemic pancreatitis.

Minerva gastroenterologica e dietologica·2020
Same journal

Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis.

Minerva gastroenterologica e dietologica·2020
Same journal

Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores.

Minerva gastroenterologica e dietologica·2020
See all related articles

Growth hormone (GH) influences lipid metabolism, affecting free fatty acids and lipoproteins. Lipids, particularly elevated fatty acids in obesity, also impact GH secretion, potentially causing GH insufficiency.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Lipidomics

Context:

  • The interplay between growth hormone (GH), Insulin Growth Factor-I (IGF-I), and lipid metabolism is complex and clinically significant.
  • Understanding these reciprocal influences is crucial for advancing scientific research and medical practice.

Purpose:

  • To analyze the impact of GH on lipid metabolism, focusing on free fatty acids (FFA) and lipoprotein metabolism.
  • To examine lipid metabolism disorders in conditions of GH hypo- and hyper-secretion.
  • To explore the role of lipids in regulating GH secretion, especially in obesity.

Summary:

  • GH significantly affects lipid metabolism, including free fatty acid and lipoprotein profiles.
  • Disruptions in lipid metabolism are observed in both GH deficiency and excess states.

Related Experiment Videos

  • Elevated FFA levels in obesity are implicated in the pathogenesis of GH insufficiency.

    • Impact:

    • Provides insights into the pathophysiology of endocrine and metabolic disorders.
    • Highlights potential therapeutic targets for managing lipid abnormalities and GH-related conditions.
    • Enhances understanding of obesity-related complications, particularly GH insufficiency.